| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Ogden Regional Medical Center is a Ogden, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1972, GMCF has been providing medical peer review and consultative services, utilization and quality management review services for Medicaid Programs.
Neovia benefits from a multi-activities, multi-species and multi-areas experience. It is a reference in terms of innovative solutions in breeding.
BENU Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Mateo, CA. To find more information about BENU Inc, please visit www.benu.com